NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
0.7390
Dollar change
+0.1100
Percentage change
17.49
%
Index- P/E- EPS (ttm)-0.09 Insider Own17.12% Shs Outstand139.08M Perf Week25.25%
Market Cap102.95M Forward P/E- EPS next Y-0.02 Insider Trans-75.40% Shs Float115.47M Perf Month5.72%
Enterprise Value131.82M PEG- EPS next Q-0.01 Inst Own20.24% Short Float0.05% Perf Quarter51.00%
Income-11.99M P/S0.84 EPS this Y82.83% Inst Trans-78.18% Short Ratio0.30 Perf Half Y86.90%
Sales122.30M P/B2.34 EPS next Y24.76% ROA-12.64% Short Interest0.06M Perf YTD66.82%
Book/sh0.32 P/C18.96 EPS next 5Y- ROE-26.20% 52W High0.83 -11.23% Perf Year18.24%
Cash/sh0.04 P/FCF- EPS past 3/5Y-29.49% 27.73% ROIC-18.11% 52W Low0.33 123.26% Perf 3Y43.97%
Dividend Est.- EV/EBITDA- Sales past 3/5Y28.50% 12.64% Gross Margin58.18% Volatility8.54% 8.49% Perf 5Y-28.94%
Dividend TTM- EV/Sales1.08 EPS Y/Y TTM-498.66% Oper. Margin-6.17% ATR (14)0.06 Perf 10Y-98.38%
Dividend Ex-Date- Quick Ratio1.03 Sales Y/Y TTM20.81% Profit Margin-9.81% RSI (14)66.44 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio2.34 EPS Q/Q101.18% SMA2014.04% Beta-0.19 Target Price1.75
Payout- Debt/Eq0.78 Sales Q/Q18.05% SMA5022.49% Rel Volume3.25 Prev Close0.63
Employees232 LT Debt/Eq0.51 EarningsMay 12 AMC SMA20038.46% Avg Volume190.08K Price0.74
IPOJul 01, 2010 Option/ShortNo / Yes EPS/Sales Surpr.3588.75% 5.39% Trades Volume618,164 Change17.49%
Date Action Analyst Rating Change Price Target Change
Dec-05-23Initiated BTIG Research Buy $2
Nov-15-18Reiterated Maxim Group Buy $10 → $6
Feb-14-18Reiterated Maxim Group Buy $18 → $10
May-28-25 08:00AM
May-12-25 04:05PM
May-06-25 08:00AM
Apr-23-25 08:00AM
Apr-16-25 08:05AM
03:05PM Loading…
Mar-06-25 03:05PM
Feb-28-25 08:00AM
Nov-12-24 04:05PM
Nov-11-24 08:00AM
Nov-07-24 10:45AM
Sep-23-24 07:00AM
Sep-18-24 06:00AM
Aug-08-24 07:20AM
07:10AM
07:05AM
08:30AM Loading…
Jul-25-24 08:30AM
May-22-24 04:35PM
May-16-24 05:00AM
May-15-24 04:05PM
May-08-24 08:30AM
Apr-30-24 05:00AM
Apr-02-24 11:19AM
01:13AM
Apr-01-24 07:00AM
Mar-21-24 04:05PM
Mar-07-24 04:05PM
Feb-26-24 04:05PM
Feb-20-24 02:01PM
Feb-05-24 08:00AM
Nov-10-23 03:41AM
04:44PM Loading…
Nov-09-23 04:44PM
08:25AM
07:00AM
Nov-02-23 04:05PM
Oct-23-23 04:05PM
Oct-12-23 04:05PM
Aug-10-23 04:15PM
Aug-02-23 02:28AM
Aug-01-23 07:00AM
Jul-28-23 03:56PM
Jul-25-23 04:05PM
Jul-07-23 08:00AM
Jul-03-23 07:27AM
May-18-23 08:00AM
May-09-23 02:59PM
May-04-23 07:00AM
Apr-27-23 08:00AM
Mar-07-23 11:19PM
07:00AM
Mar-03-23 08:00AM
Mar-01-23 09:15AM
Feb-28-23 08:00AM
Jan-09-23 08:00AM
Nov-21-22 08:00AM
Nov-03-22 07:00AM
Oct-27-22 08:00AM
Oct-11-22 08:00AM
Aug-31-22 08:00AM
Aug-24-22 08:00AM
Aug-04-22 07:00AM
Jul-28-22 08:00AM
May-05-22 08:00AM
May-02-22 08:00AM
Apr-28-22 08:30AM
Mar-15-22 08:00AM
Mar-08-22 07:00AM
Mar-01-22 08:30AM
Jan-04-22 08:00AM
Jan-03-22 08:00AM
Nov-12-21 07:00AM
Nov-05-21 08:30AM
Oct-19-21 08:00AM
Sep-07-21 08:00AM
Aug-05-21 07:00AM
Jul-29-21 04:05PM
Jun-18-21 10:46PM
May-11-21 07:15AM
07:05AM
07:00AM
May-06-21 04:05PM
May-04-21 08:30AM
Mar-03-21 05:21AM
Feb-26-21 04:05PM
12:48PM
Feb-25-21 08:30AM
Feb-24-21 07:15AM
07:00AM
Feb-22-21 08:30AM
Feb-17-21 08:30AM
Dec-07-20 08:30AM
Nov-27-20 07:07PM
Oct-29-20 07:00AM
Oct-22-20 04:05PM
Oct-20-20 09:30PM
09:30PM
08:30AM
Oct-06-20 07:00AM
Oct-02-20 07:25AM
Oct-01-20 04:05PM
Aug-24-20 08:30AM
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoSTX, Certex Spinal Fixation System, Axle Interspinous Fusion System, and Calix. The company was founded in 2006 and is headquartered in Belgrade, MT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ORBIMED ADVISORS LLC10% OwnerApr 10 '25Sale0.4273,114,59230,708,1290Apr 14 07:14 PM